Clinical Trial Details
EORTC-62005
Back to Clinical Trials Database
Phase III randomised, intergroup, international trial assessing the clinical activity of STI-571 at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumours (GIST) expressing the KIT receptor tyrosine kinase (CD117)
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 24-Jan-2001 Date Step1 close: 08-Feb-2002 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 600 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00685828 |
| NCT number | NCT00685828 |
